Medicines in Pregnancy-Women and Children First? Time for a Coalition to Address a Substantial Patient Need

Therapeutic Innovation and Regulatory Science

Volumn 47, Issue 5, 2013, Pages 528-532

  Dewulf, Lode ^a  

^a Formerly Janssen Medical Affairs Europe   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; BASIC RESEARCH; CLINICAL RESEARCH; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; EXPECTANT MOTHER; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; LIFESTYLE MODIFICATION; MATERNAL CARE; PATIENT ATTITUDE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SELF MEDICATION; UNPLANNED PREGNANCY;

EID: 84883510323     PISSN: 21684790     EISSN: 21649200     Source Type: Journal    
DOI: 10.1177/2168479013497597     Document Type: Review

References (14)

1. Centers for Disease Control & Prevention. Use of medications in pregnant women. http://www.cdc.gov/pregnancy/meds/data.html. Accessed August 5, 2013.
2. Sachdeva P,Patel BG,Patel BK.Drug use in pregnancy: a point to ponder!.Indian J Pharm Sci. 2009;71 (1): 1-7.
3. Eichler H-G,Abadie E,Baker M,Rasi G.Fifty years after thalidomide: what role for drug regulators?.Br J Clin Pharmacol. 2012;74 (5): 731-733.
4. Murk W,Seli E.Fertility preservation as a public health issue: an epidemiological perspective.Curr Opin Obstet Gynecol. 2011;23:143-150.
5. UNECEStatistical Division Database. Geneva,Switzerland: United Nations Economic Commission for Europe; 2012. http://w3.unece.org/pxweb/dialog/varval.asp?ma=04_GEFHAge1stChild_r&path=./database/STAT/30-GE/02-Families_households/&lang=1&ti=Mean+age+of+women+at+birth+of+first+child.
6. Clowse ME,Chakravarty E,Costenbader KH,Chambers C,Michaud K.Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus.Arthritis Care Res (Hoboken). 2012;64 (5): 668-674.
7. Hämeen-Anttila K,Jyrkkä J,Enlund H,Nordeng H,Lupattelli A,Kokki E.Medicines information needs during pregnancy: a multinational comparison.BMJ Open. 2013;3:e002594.
8. Peters S,Lind J,Humphrey J, et al.Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from web-based information, 2011.Pharmacoepidemiol Drug Saf. 2013;22 (3): 324-328.
9. Finer LB,Henshaw SK.Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.Perspect Sex Reprod Health. 2006;38:90-96.
10. Cragan JD,Friedman JM,Holmes LB,Uhl K,Green NS,Riley L.Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care.Matern Child Health J. 2006;10 (5 Suppl): S129-S135.
11. Koren G.Pharmacokinetics in pregnancy: clinical significance.J Popul Ther Clin Pharmacol. 2011;18 (3): e523-e527.
12. Goldkind SF,Sahin L,Gallaureso B.Enrolling pregnant women in research: lessons from the H1N1 influenza pandemic.N Engl J Med. 2010;362:2241-2243.
13. GrovesPKayyaliBKnottDVan KuikenS. The 'big data' revolution in healthcare. Available at:www.mckinsey.com. Accessed January2013.
14. Thürmann PA,Steioff A.Drug treatment in pregnancy.Int J Clin Pharmacol Ther. 2001;39 (5): 185-191.